From a practical perspective, urine biomarkers—notably NGAL, KIM-1, MCP-1, and DKK3—offer non-invasive, rapid, and repeatable testing; among them, urinary NGAL and KIM-1 are currently the closest to routine clinical adoption for early detection and ongoing monitoring of kidney injury. The gene discussed is HAVCR1; the disease is kidney injury.